SCHEMBL24322143

SCHEMBL24322143

CO[n+]1ccc(C(C)C)c2sc(-c3nc(Cl)ncc3F)cc21

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CCND1 P24385 2/20 0.37
CDK4 P11802 1/20 0.37
CDK6 Q00534 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25695039 0.85 CCND1 (0.38) CCND1CDK4CDK6
SCHEMBL29514972 0.85 CCND1 (0.38) CCND1CDK4CDK6
SCHEMBL24322338 0.76 CCND1 (0.59) CCND1CDK4CDK6
SCHEMBL29755049 0.66 SMN1; SMN2 (0.35)
SCHEMBL24676493 0.66 SMN1; SMN2 (0.35)
SCHEMBL394534 0.64 ABL1 (0.34)
SCHEMBL25695270 0.64 CCND1 (0.41) CCND1CDK4CDK6
SCHEMBL24054302 0.63 ADORA2A (0.37)
SCHEMBL2878488 0.62 CDK4 (0.32) CCND1CDK4
SCHEMBL4075180 0.62 DCK (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022061273-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS, INCORPORATED (US) 2022-03-24 WO disclosed